ClinicalTrials.Veeva

Menu

Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest (SACRE)

C

Centre Hospitalier Universitaire de Besancon

Status

Unknown

Conditions

Cardiac Arrest

Treatments

Device: Aspect BIS XP (A-2000) Bispectral Index Patient Monitor

Study type

Interventional

Funder types

Other

Identifiers

NCT02869997
P/2012/128

Details and patient eligibility

About

The aim of this study is to evaluate the prognostic value of the suppression ratio monitored by Bispectral Index for prediction of neurologic outcome after cardiac arrest. All patient admitted to our intensive care unit after a cardiac arrest are included. The results of the suppression ratio will be collected in the 6 first hours of admission. We will evaluate the link between suppression ratio and cerebral performance category score collected at three months.

Enrollment

102 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult
  • Cardiac arrest admitted to the ICU

Exclusion criteria

  • Pregnancy

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

102 participants in 1 patient group

Single arm
Experimental group
Description:
arm wherein all patients Suppression Ratio evaluated by BIS will be collected
Treatment:
Device: Aspect BIS XP (A-2000) Bispectral Index Patient Monitor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems